Zomedica Announces Webinar on Evidence in Veterinary Medicine

Zomedica Corp., an animal health company, is hosting its next "Fourth Friday at Four" webinar on October 23, 2026. Titled "Zomedica's Clinical Program: How Evidence Drives Adoption," the session aims to engage current and potential investors by delving into the clinical studies undertaken with veterinary professionals. These studies are designed to underscore how scientific evidence promotes the use of Zomedica's innovative diagnostic and therapeutic products.

The webinar will highlight findings from clinical trials across three of Zomedica's product lines. Each study is presented by a member of Zomedica's veterinary services team, illustrating how evidence can lead veterinarians to choose Zomedica products for their practices, whether as a first purchase or an expansion of existing services.

CEO Larry Heaton commented on the importance of evidence in bolstering the company's market adoption and recurring revenue streams. This session is a chance for investors to understand Zomedica's commitment to evidence-based product development and its impact on the veterinary industry.